polyglactin 910

Small moleculeexperimental

Clinical trial activity

4 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
4

Earliest trial started Nov 30, 2009 (NCT01019447)

Timeline

No events for the selected filters.

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
Yes

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • polyglactin 910
  • polyglactin 910
  • vicryl
  • vicryl
  • xlg
  • xlg

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05330650Phase 4Nov 1, 2020Ben Arous Hospital, Tunis, Tunisia, Tunis University
NCT04256824Phase 4Feb 10, 2020Al Safwa Hospital, Al Zohour Hospital, ClinAmygate, Minia University, Misr University for Science and Technology, MSKMC Univeristy Hospital
NCT04255927Phase 4Feb 8, 2020Al Safwa Hospital, Cairo University, ClinAmygate, Misr University for Science and Technology
NCT01019447Phase 4Nov 30, 2009Cairo University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Al Safwa HospitalAcademic/Hospital2012020
Cairo UniversityAcademic/Hospital2112009
ClinAmygateFor profit2212020
Misr University for Science and TechnologyAcademic/Hospital2012020
Al Zohour HospitalAcademic/Hospital1012020
Ben Arous Hospital, Tunis, TunisiaAcademic/Hospital1012020
Minia UniversityAcademic/Hospital1012020
MSKMC Univeristy HospitalAcademic/Hospital1012020
Tunis UniversityAcademic/Hospital1112020
9 organizations
Page 1 / 1